Lino Silva Ferreira holds a Ph.D. in Biotechnology from the University of Coimbra (Portugal). He did postdoctoral work at INEB and MIT (USA) in the areas of stem cells and nanotechnologies. He joined the Center of Neurosciences and Cell Biology (CNC, University of Coimbra) in 2008. He is the director of the Biomaterials and Stem Cell-Based Therapeutics research group, CNC coordinator of the MIT-Portugal Program and the founder of the biotech company Matera. In 2012, he was awarded with a prestigious European Research Council starting grant and in 2016 an ERA Chair position at the University of Coimbra. His research group has interest in the development of tissue models from stem cells and in the use nanomedicine platforms to modulate the activity of endogenous (stem) cells.